PLTR News: Palantir Technologies gains as the bulls come to the rescue
Premium|Take advantage of 60% OFF on your first month.
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
CLAIM OFFER- NYSE:PLTR added 0.98% on Tuesday amidst a down day for the broader markets.
- More complaints out of the NHS as researchers are concerned about access to Palantir’s platform.
- Palantir is a rare stock that both Reddit and Hedge Funds love to accumulate.
NYSE:PLTR started the week the way its investors were hoping after three straight losing days heading into the July Fourth long weekend. On Tuesday, shares of Palantir added 0.98% to close the trading session at $24.68. The move was a positive one, especially after the broader markets fell sharply to begin the session after news of slower economic recovery and a potential decrease in COVID-19 vaccine efficacy against the new delta variant looms. Palantir is still trading between its 50-day and 200-day moving averages, as the stock remains poised for a bullish breakout.
Stay up to speed with hot stocks' news!
Palantir’s introduction to the UK’s NHS was a rocky one, as British citizens protested the use of the company’s Foundry platform following its announcement earlier this year. Now, NHS researchers are concerned that their access to the COVID-19 database that is run through Foundry has been limited with no immediate response from Palantir as to why. While this could be more of a case of NHS management restricting access to staff, it doesn’t help that Palantir’s name is associated with these issues, especially after the critical response to its inception just a few months ago.
PLTR stock forecast
Shares of Palantir continue to garner support from both retail and institutional investors, as mega funds like Ark Invest, Citadel, and Stanley Druckenmiller’s Duquesne Family Office have all built large positions in the stock. Likewise the stock continues to be one of the most widely discussed stocks on Reddit forums, reiterating the fact that retail investors are also well invested in Palantir for the long-term.
- NYSE:PLTR added 0.98% on Tuesday amidst a down day for the broader markets.
- More complaints out of the NHS as researchers are concerned about access to Palantir’s platform.
- Palantir is a rare stock that both Reddit and Hedge Funds love to accumulate.
NYSE:PLTR started the week the way its investors were hoping after three straight losing days heading into the July Fourth long weekend. On Tuesday, shares of Palantir added 0.98% to close the trading session at $24.68. The move was a positive one, especially after the broader markets fell sharply to begin the session after news of slower economic recovery and a potential decrease in COVID-19 vaccine efficacy against the new delta variant looms. Palantir is still trading between its 50-day and 200-day moving averages, as the stock remains poised for a bullish breakout.
Stay up to speed with hot stocks' news!
Palantir’s introduction to the UK’s NHS was a rocky one, as British citizens protested the use of the company’s Foundry platform following its announcement earlier this year. Now, NHS researchers are concerned that their access to the COVID-19 database that is run through Foundry has been limited with no immediate response from Palantir as to why. While this could be more of a case of NHS management restricting access to staff, it doesn’t help that Palantir’s name is associated with these issues, especially after the critical response to its inception just a few months ago.
PLTR stock forecast
Shares of Palantir continue to garner support from both retail and institutional investors, as mega funds like Ark Invest, Citadel, and Stanley Druckenmiller’s Duquesne Family Office have all built large positions in the stock. Likewise the stock continues to be one of the most widely discussed stocks on Reddit forums, reiterating the fact that retail investors are also well invested in Palantir for the long-term.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.